ACHE and neurodegenerative disease: As molecular docking and MD simulations continue to evolve, their combined application will remain a cornerstone in the development of highly selective, reversible, and effective AChE inhibitors, paving the way for improved therapeutic strategies against neurodegenerative diseases.